Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Granules India
Add new alert
GRANULES •
NSE
Granules India
₹633.15
12.75 (2.06%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
Livesquawk •
2 hours ago
Granules India's Shamirpet facility cleared by US FDA after inspection. US FDA clearance granted to Granules Life Sciences for compliance.
Moneycontrol •
3 hours ago
Granules India's unit got VAI status after USFDA inspection of its Telangana facility. The stock is 2.95% below its 52-week high and up 50.8% from its 52-week low.
Livesquawk •
21 hours ago
Granules: US FDA inspection led to voluntary action classification. Post-inspection closure, FDA took no further regulatory action.
ScoutQuest •
23 hours ago
Granules Life Sciences received VAI classification from US FDA post inspection. Inspection covered cGMP, pre-approval; no regulatory action recommended, enhancing production.
Marketsmojo •
3 days ago
Granules India signals bullish momentum despite a slight session dip. Robust moving averages and MACD readings support medium-term prospects.
NDTV Profit •
5 days ago
Analysts recommend Laurus Labs, BHEL, Granules India, SBI, and Sun Pharma for strong upside, citing technical and fundamental strengths. Laurus Labs, BHEL, and Sun Pharma show bullish setups; SBI benefits from credit growth, while Granules India leverages cost-efficient production.
Business Standard •
5 days ago
Granules India, Aurobindo Pharma, and Wheels India emerge as top picks with bullish setups. Analyst recommends buying Granules at ₹629, Wheels at ₹1,090, and Aurobindo at ₹1,308 with specific targets.
CNBC TV 18 •
4 weeks ago
Granules India's Virginia facility cleared USFDA inspection with zero observations, marking its second successful audit. Q3 results showed net profit up 27.7% to ₹150.2cr; revenue rose 22% to ₹1,387.9cr, lifting margins to 22.2%.
Livesquawk •
4 weeks ago
Granules India's US subsidiary received a favorable FDA report with no action needed. The facility is vital for OTC product packaging and distribution.
MarketScreener India •
1 month ago
Granules India reported Q3 revenue of INR 13.9bn, up 22% YoY, driven by strong sales in North America and Europe. The stock has risen 15.6% in 12 months with analysts maintaining a Buy stance and a target price of INR 645.7.